Document is current
Any future updates will be listed below
-
Authors
Attar, Armin https://orcid.org/0000-0002-4133-4870
Monabati, Ahmad
Montaseri, Mohammad
Vosough, Massoud
Hosseini, Seyed Ali
Kojouri, Javad
Abdi-Ardekani, Alireza
Izadpanah, Peyman
Azarpira, Negar
Pouladfar, Gholamreza
Ramzi, Mani
-
Funding
Funding for this research was provided by:
Shiraz University of Medical Sciences (SG-98-5, SG-98-94, and SG-96-86)
- License Information
-
More Information
Article History
Received: 25 October 2021
Accepted: 25 July 2022
First Online: 4 August 2022
Declarations
:
: We discussed all ethical issues with the Institutional Review Board of Shiraz University of Medical Sciences, which ultimately approved the study protocol (IR.SUMS.REC.1400.409). Informed consent will be obtained once patients are clinically stable and sedatives or strong analgesics do not alter their consciousness.
: Written consent will be obtained from all patients for publication of their data following deidentification.
: M. V. is the regulatory affairs manager in Cell Tech Pharmed. Cell Tech Pharmed Co. will provide us with cGMP grade WJ-MSCs but is not involved in the design or interpretation of the research.
